Form 8-K - Current report:
SEC Accession No. 0001628280-17-004499
Filing Date
2017-04-28
Accepted
2017-04-28 16:58:20
Documents
1
Period of Report
2017-04-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K- APRIL 2016 VOTE OF ANNUAL SH MEETING a8k-april2017xvoteofannual.htm 8-K 57735
  Complete submission text file 0001628280-17-004499.txt   58777
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 17796653
SIC: 2834 Pharmaceutical Preparations